Recall: D-0096-2026

Class II - Potentially Harmful

Class IIClassification

2025-10-10Initiated

OngoingStatus

Lannett Company Inc.Firm

Product

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46

Reason

Failed Dissolution Specifications

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.